| Literature DB >> 33759076 |
Dyre Kleive1, Eline Aas2,3, Jon-Helge Angelsen4, Erling A Bringeland5, Arild Nesbakken6,7, Linn S Nymo8, Johannes K Schultz9, Kjetil Søreide10,11, Sheraz Yaqub12,13.
Abstract
The timing of surgical resection of synchronous liver metastases from colorectal cancer has been debated for decades. Several strategies have been proposed, but high-level evidence remains scarce. Simultaneous resection of the primary tumour and liver metastases has been described in numerous retrospective audits and meta-analyses. The potential benefits of simultaneous resections are the eradication of the tumour burden in one procedure, overall shorter procedure time, reduced hospital stay with the likely benefits on quality of life and an expected reduction in the use of health care services compared to staged procedures. However, concerns about accumulating complications and oncological outcomes remain and the optimal selection criteria for whom simultaneous resections are beneficial remains undetermined. Based on the current level of evidence, simultaneous resection should be restricted to patients with a limited liver tumour burden. More high-level evidence studies are needed to evaluate the quality of life, complication burden, oncological outcomes, as well as overall health care implications for simultaneous resections.Entities:
Keywords: Colorectal cancer; Colorectal resection; Liver resection; Simultaneous resection; Surgical oncology; Surgical outcomes; Synchronous liver metastasis
Year: 2021 PMID: 33759076 DOI: 10.1007/s40487-021-00148-2
Source DB: PubMed Journal: Oncol Ther ISSN: 2366-1089